‘Domestic rare disease treatments’ grew as leading products
Pricey rare disease treatments have grown as leading products of domestic pharmaceutical companies.
Since they are expensive as essential drugs despite the small number of patients needing them, their sales have been significantly raised.
‘Pirespa,’ the Ildong Pharmaceutical’s only idiopathic ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
